Risk communication in genetic testing for cancer susceptibility.
about
Accuracy of recall of information about a cancer-predisposing BRCA1/2 gene mutation among patients and relatives.Communication and decision making in cancer care: setting research priorities for decision support/patients' decision aidsUsing collaborative web technology to construct the health information national trends surveyImplications of Internet availability of genomic information for public health practiceEthical issues evolving from patients' perspectives on compulsory screening for syphilis and voluntary screening for cervical cancer in KenyaDesign of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counsellingSubjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.Patient perspective on the value of genetic counselling for familial pancreas cancerPsychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.Perceived intrafamily melanoma risk communication.Impact of genetic notification on smoking cessation: systematic review and pooled-analysis.Risky feelings: why a 6% risk of cancer does not always feel like 6%Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.Development of a communication protocol for telephone disclosure of genetic test results for cancer predispositionAttitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.What are the chances? Evaluating risk and benefit information in consumer health materialsGenetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest.Effect of misreported family history on Mendelian mutation prediction modelsConsumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial.Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era.Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.Risk perception after genetic counseling in patients with increased risk of cancer.Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study.Beliefs about heritability of cancer and health information seeking and preventive behaviors.Ethical issues of predictive genetic testing for diabetes.The impact of personalized risk feedback on Mexican Americans' perceived risk for heart disease and diabetes.Communicating with Daughters About Familial Risk of Breast Cancer: Individual, Family, and Provider Influences on Women's Knowledge of Cancer Risk.Using an Internet-Based Breast Cancer Risk Assessment Tool to Improve Social-Cognitive Precursors of Physical Activity.Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
P2860
Q27324685-54666999-16D3-4CA4-A3C5-5BCE1929EEB7Q28660440-C23641B0-C21A-455F-94E6-03785F442B26Q28714237-10EA4B20-C01A-42E9-ADEF-FC7501B231A0Q28729140-1912EAD5-4F37-4D2B-B949-036D1263FF3CQ30391950-1104EA8C-E22D-4802-8BC9-7BFFD6FC4C35Q33373818-E8FB8506-DB7B-4429-B8CC-7C675EA50B5CQ33589900-A391B7BC-A429-40FD-B008-65BE3F5298C9Q33605457-6DD469F1-FBFA-48CB-90A5-1DE6F07B460DQ33638941-0A7C4EEA-0825-4952-A931-5A73E160897BQ33722522-E86DC8B3-18D2-4609-9C6A-9D54928654DFQ33955566-62C36009-BD87-463D-8B75-B20B0E31EAF1Q34019110-596F88A3-D56C-4A86-BB0A-F0F29F0D7504Q34341888-54297D27-B45C-45B4-90F8-080243AD7832Q34361319-F55CF778-5144-45F4-927F-7185B8361EDEQ34624868-BA808D0C-7220-4098-86A2-9BAA46C410E9Q34657518-58B1948B-CCAE-41A1-9AAB-CDBAF035BFA5Q35601519-B3788E60-9B6A-4108-8F45-3ED0815404D4Q35751200-4BEFCAD3-32CC-4DA7-BF9A-62F11C6E1CF8Q35758762-12B87D95-0CE1-49F4-8D37-BD1BE5218F2BQ36507515-8FE94167-8E83-4E75-9EA7-842CD8BD0106Q36526904-CE7F5F97-C9DD-4832-8DD8-3945AB50989CQ36678417-39C83AA4-0336-4CD3-A774-D65F694C075AQ36926475-E882BDAC-8EEA-410E-A4AB-64F57A1B3753Q37040188-73A03746-1591-46DC-912D-E03CEF1EE4E6Q37348988-AC96575F-19FA-483F-B871-C1EAF11F318DQ37385214-40BD0CCA-A98A-4672-93D2-50355005459BQ37402720-88A90F8F-A675-4369-9693-FA0BA3266E0DQ37404594-2ABC95F6-0C9A-4390-B942-D96EA1E24B84Q37646697-6A694755-BB2B-4DB8-87D0-B188479CBB32Q47552443-BF168129-933A-4692-A6BD-628B18031FEAQ47932504-0A8D8538-5997-4F44-92D1-D8D3BA044EA6Q52087320-5EC93853-D19C-4C87-B032-43F9F1F93DEC
P2860
Risk communication in genetic testing for cancer susceptibility.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Risk communication in genetic testing for cancer susceptibility.
@ast
Risk communication in genetic testing for cancer susceptibility.
@en
type
label
Risk communication in genetic testing for cancer susceptibility.
@ast
Risk communication in genetic testing for cancer susceptibility.
@en
prefLabel
Risk communication in genetic testing for cancer susceptibility.
@ast
Risk communication in genetic testing for cancer susceptibility.
@en
P1476
Risk communication in genetic testing for cancer susceptibility.
@en
P2093
P577
1999-01-01T00:00:00Z